Takeda & Baxter aim to set up cell culture site in Japan
Takeda is collaborating with Baxter to establish a Vero cell-based influenza manufacturing facility in Japan and launch vaccines in the country.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs